CTRI/2023/03/050650尚未招募不适用
Effect of perioperative topical nepafenac 0.3% on central macular thickness after cataract surgery in patients with diabetes: A randomized controlled trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 136
- 试验地点
- 1
- 主要终点
- To determine the effect of perioperative nepafenac 0.3% on central macular thickness after uneventful cataract surgery in diabetes
研究概览
简要总结
Title of the dissertation: Effect of perioperative topical nepafenac 0.3% on central macular thickness after cataract surgery in patients with diabetes: A randomized controlled trial
Primary objectives: To determine the effect of perioperative nepafenac 0.3% on central macular thickness after uneventful cataract surgery in diabetesSecondary objectives: To determine the association of the effect of nepafenac (0.3%) with post cataract surgery visual acuity**.**
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 40.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •All diabetic patients in the age group 40yrs and above, will be undergoing routine cataract surgery.
排除标准
- •â€¢Preexisting macular diseases/ macular oedema •Recent intraocular surgery other than cataract surgery for 3 months •Intra operative complications during the surgery •Allergic or hypersensitive to NSAIDS, corticosteroids •Chronic and recurrent inflammatory eye diseases.
- •â€¢Use of any eye drops in last three months.
- •â€¢Diseases causing macular edema other than diabetes are age related macular degeneration, Retinal venous occlusion, Coats disease, Radiation retinopathy, choroidal tumors and retinitis pigmentosa Other drugs like chloroquine, tamoxifen and interferon can induce macular edema.
结局指标
主要结局
To determine the effect of perioperative nepafenac 0.3% on central macular thickness after uneventful cataract surgery in diabetes
时间窗: Follow up day 1, day-7, day 28
次要结局
- To determine the association of the effect of nepafenac (0.3%) with post cataract surgery visual acuity.(Follow up day 1, day-7, day 28)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract SurgeryCataractNCT00333255Alcon Research267
尚未招募
Unknown
Effect of non steroidal anti-inflammatory eye drop(nepafenac) on eye(choroidal thickness) of diabetic patients without retinopathy (an end organ damage affecting eye) following cataract surgeryCTRI/2024/05/066781nil
已完成
4 期
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract SurgeryCystoid Macular EdemaNCT00494494University of North Carolina, Chapel Hill82
已完成
4 期
Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane SurgeryEpiretinal MembraneNCT00818844Alcon Research40
招募中
不适用
Priventive effect of nepafenac ophtalmic solution for changing of foveal thickness after cataract surgery.macular edema after cataract surgeryJPRN-UMIN000006671Tokyo women's medical university diabetic center opthalmology depertment60